AltaMed's Nonprofit Structure Gets Fresh Scrutiny as Split-Dollar Loan Program Details Emerge

Since July 11 coverage established that AltaMed Health Services reported $1.72 billion in 2024 revenue and paid CEO Castulo de la Rocha, his wife Zoila Escobar, and one of their sons more than $32 million since 2001, additional detail on how that compensation structure operates has come into focus.

The Split-Dollar Program

Following external scrutiny of executive pay more than a decade ago, AltaMed adopted a split-dollar life insurance loan program, according to reporting by Jeff Patch via RealClearMarkets. The arrangement allows the organization to make loans to a select group of senior leaders to finance life insurance policies.

Split-dollar programs are technically legal under IRS rules. Critics argue they function as a back-channel compensation mechanism that is harder for the public to track than a straightforward salary line on a Form 990. Supporters counter that such programs are common tools for talent retention in large, complex organizations competing against for-profit health systems for executive talent.

AltaMed has not been charged with any violation related to the program. No investigation has been publicly announced.

Why This Structure Matters

AltaMed is one of the nation's largest federally qualified health center (FQHC) systems, operating more than 70 clinics across Southern California with roughly 5,000 employees and more than 700,000 patients. It reported $1.66 billion in assets and a $68.4 million revenue surplus in 2024.

FQHCs receive enhanced federal reimbursement rates under Medicaid and Medicare, meaning a significant portion of AltaMed's revenue flows directly from taxpayers. Unlike a publicly traded company, AltaMed answers to no shareholders. Its primary accountability mechanism is a board of directors whose job is ensuring charitable resources serve public benefit.

That governance gap is the crux of the broader policy question: at what organizational scale does a nonprofit's traditional oversight structure stop being adequate?

Peer Comparisons

The compensation gap between AltaMed's leadership and peer organizations is documented. The chief executives of Family Health Centers of San Diego, Family HealthCare Network, and Comprehensive Community Health Centers each earned substantially less than de la Rocha in 2024, according to RealClearMarkets, despite running similarly large healthcare operations.

That comparison is relevant because FQHC leaders often argue that compensation must match the complexity of running large healthcare systems. The peer data suggests that argument does not fully explain AltaMed's pay levels.

The Strongest Defense

The good-faith case for AltaMed's pay structure deserves a clear statement. Running a $1.72 billion healthcare organization serving 700,000 low-income patients in one of the most expensive labor markets in the country is genuinely difficult. If below-market pay drives out experienced leadership and the organization deteriorates, patients lose. Retention tools like split-dollar life insurance are standard in large nonprofit hospital systems nationwide, not an AltaMed invention. And a $68.4 million surplus on $1.72 billion in revenue is a margin of roughly 4 percent, not a figure that suggests resources are being stripped from patient care at scale.

Those are real arguments. They don't resolve the governance question, but they complicate any simple narrative.

The Unresolved Question

What the AltaMed case crystallizes is a systemic design problem. The nonprofit designation was built for organizations of a different scale. A community health center with a $2 million budget and a board of local volunteers operates under fundamentally different accountability dynamics than a $1.7 billion enterprise drawing heavily on federal reimbursements.

Congress has periodically explored tightening FQHC executive compensation disclosure requirements, but no legislation is currently moving. The IRS's Form 990 requires disclosure of compensation for the five highest-paid employees, which captures salary and bonus figures but makes loan-based arrangements like split-dollar programs significantly harder for outside observers to evaluate.

The specific unresolved question as of July 11, 2026: whether AltaMed's board conducted an independent compensation benchmarking study that included the split-dollar loan valuations when setting de la Rocha's total package, and whether that study has ever been disclosed publicly. RealClearMarkets' reporting does not establish that it has.